Literature DB >> 27076143

The Design of a Clostridium difficile Carbohydrate-Based Vaccine.

Mario A Monteiro1.   

Abstract

Clostridium difficile vaccines composed of surface polysaccharides (PSs) have the potential to simultaneously control infection and colonization levels in humans. Hot water-phenol treatment of C. difficile biomass can extricate water-soluble PS-I and PS-II; and water- and phenol-soluble PS-III. C. difficile vaccines based on PS-II have attracted the most attention due its facile purification and ubiquitous expression by C. difficile ribotypes. Anti PS-II antibodies recognize both C. difficile vegetative cell and sporulating preparations and confer protection against C. difficile infection in a mouse model. The design of such an efficacious C. difficile PS-II conjugate vaccine is described here.

Entities:  

Keywords:  C. difficile PS-II; Clostridium difficile; Conjugate; Polysaccharide; TEMPO-mediated conjugation; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27076143     DOI: 10.1007/978-1-4939-3387-7_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge.

Authors:  Gillian A Lang; Binu Shrestha; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

Review 2.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

Review 3.  Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

Authors:  Séverine Péchiné; Jean F Bruxelle; Claire Janoir; Anne Collignon
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

Review 4.  Carbohydrate Scaffolds for the Study of the Autism-associated Bacterium, Clostridium bolteae.

Authors:  Brittany Pequegnat; Mario A Monteiro
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

5.  Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands.

Authors:  Gillian A Lang; Kaylee Norman; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

6.  Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection.

Authors:  Anna P Soavelomandroso; Françoise Gaudin; Sandra Hoys; Valérie Nicolas; Gayatri Vedantam; Claire Janoir; Sylvie Bouttier
Journal:  Front Microbiol       Date:  2017-10-25       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.